InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by JANTZ DEREK, Directeur Scientifique. Officer active across 1 companies, notably Precision Biosciences INC. Cumulatively, 7 reports have been published. Total volume traded: €309k. The latest transaction was disclosed on 17 May 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
29,545 shares
Common Stock
SEC:0001209191-22-035417:0·
€154,31620,000 shares@ €7.71580.15% mcap99.1% of flow
Common Stock
SEC:0001209191-21-033864·
€154,31620,000 shares@ €7.71580.15% mcap49.5% of flow
Common Stock
SEC:0001209191-21-033864:0·
€71321,514 shares@ €0.03310.0007% mcap0.5% of flow
Common Stock
SEC:0001209191-21-033487·
€71321,514 shares@ €0.03310.0007% mcap0.2% of flow
Common Stock
SEC:0001209191-21-033487:0·
€71221,514 shares@ €0.03310.0007% mcap0.5% of flow
Common Stock
SEC:0001209191-21-032764·
€71221,514 shares@ €0.03310.0007% mcap0.2% of flow
Common Stock
SEC:0001209191-21-032764:0·
7 of 7 declarations
About JANTZ DEREK
Derek Jantz is the Chief Scientific Officer at Precision Biosciences Inc. He oversees the company's research and development initiatives, focusing on innovation in the biotechnology field. His role is crucial for the development of new therapies and scientific solutions. Precision Biosciences Inc. is known for its advancements in genome editing and stem cell-based treatments.
